| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $119.5M | +4.1% |
| SG&A Expense | $49.7M | +0.2% |
| Operating Income | -$169.3M | -2.9% |
| Income Tax | $2.3M | — |
| Net Income | -$156.8M | -33.1% |
| EPS (Basic) | -$2.70 | -43.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.4M | -52.1% |
| Short-term Investments | $86.7M | -47.4% |
| Accounts Receivable | $7.7M | -4.4% |
| Current Assets | $134.1M | -38.4% |
| Total Assets | $277.1M | -26.8% |
| Current Liabilities | $79.5M | +49.2% |
| Long-term Debt | $164.9M | -22.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$148.8M | -299.1% |
| Capital Expenditures | $165K | -61.3% |
| Investing Cash Flow | $82.2M | +199.5% |
| Financing Cash Flow | $62.9M | +159.3% |
| Free Cash Flow | -$149.0M | -300.5% |
| Stockholders' Equity |
| -$182.6M |
| -630.9% |